NIKA PHARMACEUTICALS, INC. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
NIKA PHARMACEUTICALS, INC. (NIKA) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $43.29 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2026-03-25
- NIKA PHARMACEUTICALS, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2024-06-30 was $43.46K.
- NIKA PHARMACEUTICALS, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2024-03-31 was $76.34K.
- NIKA PHARMACEUTICALS, INC. business combination, consideration transferred, equity interests issued and issuable for fiscal 2024 was $43.29K.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month as first filed | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 6 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|---|---|---|
| 2024-12-31 | $43.29K 10-K · filed 2026-03-25 | |||
| 2024-06-30 | $43.46K 10-Q · filed 2025-11-07 | $91.39K 10-Q · filed 2024-09-18 | $119.81K derived: sum of 2 quarters · filed 2025-11-07 | |
| 2024-03-31 | $76.34K 10-Q · filed 2025-11-07 |